L W Fang

ORCID: 0009-0002-6666-6529 · 1 paper in corpus · active 2019

Study types

  • article 1
article 2019
[Ruxolitinib combined with prednisone, thalidomide and danazol for treatment of myelofibrosis: a pilot study].
·doi:10.3760/cma.j.issn.0253-2727.2019.01.005

RUX combined with PTD for treatment of MF may modulate initial hematologic toxicity observed when RUX alone, and may increase response due to improved levels of hemoglobin or platelet.